Caliway Biopharmaceuticals Co., Ltd.
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING2
READOUTS ≤12 MONTHS3
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| CBL-514 Injection NCT07608770 |
P2 | Recruiting | Subcutaneous Fat | 250 | 2027-04 |
| SUPREME-01 NCT07140939 |
P3 | Recruiting | Subcutaneous Fat | 320 | 2027-07 (+12 mo) |
| CBL-514 Injection NCT07526974 |
P3 | Not yet recruiting | Subcutaneous Fat | 320 | 2027-08 |
| CBL-514 Injection NCT07608757 |
P2 | Not yet recruiting | Subcutaneous Fat | 250 | 2028-02 |
| CBL-514 Injection NCT07733947 |
P3 | Not yet recruiting | Subcutaneous Fat | 300 | 2028-08 |